Unlabelled: Conflicts with methadone program counseling staff and violations of program rules can contribute to patients leaving treatment prematurely. This qualitative study was conducted as part of a larger trial of patient-centered methadone treatment (PCM). In-depth, semi-structured interviews at baseline and 12-month follow-up were conducted with five counselors and three clinical supervisors from the programs participating in the PCM parent study. Data were analyzed using Atlas.ti. Counselors reported that, in some cases, PCM allowed them to focus on building a therapeutic alliance with patients because they were not addressing program rule issues. Some reported using more pro-active, innovative strategies for engaging PCM patients and that counseling sessions tended to include a broader range of individually tailored topics, compared to topics normally addressed in typical treatment sessions. Adjusting to the new counselor role was challenging for some counselors and required a shift in tactics to encourage patients' participation in counseling services.
Clinical Trial Registration: Clinicaltrials.gov NCT 01442493.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11414-018-9603-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics.
Addict Sci Clin Pract
December 2024
Community Medical Services, Phoenix, AZ, USA.
Background: U.S. policy intervention to increase methadone treatment accommodations during COVID did not result in national adoption of the new patient-centered treatment practices.
View Article and Find Full Text PDF"Tethered to this ball and chain": Women's perspectives on bodily agency within opioid treatment programs.
Int J Drug Policy
December 2024
Consortium on Substance Use and Addiction, Pennsylvania State University, USA; Department of Human Development and Family Studies, Pennsylvania State University, USA.
Article Synopsis
- Methadone Maintenance Treatment (MMT) is effective in reducing risks related to opioid use disorder (OUD), but less than 10% of those affected in the U.S. receive it, particularly among women involved in the criminal justice system.
- A study involving interviews with women in Pennsylvania and substance use disorder professionals highlighted that women feel their bodily agency is compromised by strict OTP policies, which can harm their treatment experience and retention.
- The research calls for MMT programs to adopt a more patient-centered and trauma-informed approach, emphasizing the importance of empowering women in their treatment decisions to enhance effectiveness.
Patient experiences in outpatient substance use disorder treatment: A qualitative study exploring both clinical and non-clinical contexts.
J Subst Use Addict Treat
November 2024
Department of Population Health, New York University Grossman School of Medicine, New York City, NY, United States of America.
Background: Addressing the persistent treatment gap in substance use disorder (SUD) remains a critical challenge, with only 13 % of Americans with SUDs receiving necessary treatment. We explored the complexities of engaging in SUD treatment from patients' perspectives and aims to provide a comprehensive understanding of their treatment experiences.
Methods: We conducted semi-structured interviews with 34 patients who had been attending outpatient SUD clinics in New York State for 6 or less months.
High dose opioid agonist therapy for patients with opioid use disorder: a case series exploring this patient-centered approach.
J Addict Dis
September 2024
Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Objectives: Management of opioid withdrawal in the inpatient setting can vary widely depending on the patient, the physician, and the institution. Although buprenorphine and methadone are first-line therapy for withdrawal management, some patients experience barriers to those medications. In this case series, we explore high dose opioid agonist therapy (HDOAT) as a novel and effective option to bridge to recovery in this particular setting.
View Article and Find Full Text PDFOpioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial.
Am J Addict
January 2025
British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.
Background And Objectives: History of nonfatal overdose (NFO) is common among people who use opioids, but little is known about opioid agonist treatment (OAT) outcomes for this high-risk subpopulation. The objective of this study was to investigate the relative effectiveness of buprenorphine/naloxone and methadone on retention and suppression of opioid use among individuals with opioid use disorder (OUD) and history of NFO.
Methods: Secondary analysis of a pan-Canadian pragmatic trial comparing flexible take-home buprenorphine/naloxone and supervised methadone for people with OUD and history of NFO.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!